Merck Sharp & Dohme Ltd withdraws its marketing authorisation application for Vorinostat MSD

The European Medicines Agency (EMEA) has been formally notified by Merck Sharp & Dohme Ltd of its decision to withdraw its application for a centralised marketing authorisation for the medicine Vorinostat MSD (vorinostat), 100 mg hard capsules. ... Read more